Phase 2 Study of the PARP Inhibitor Olaparib

Grant Details

Grantee Name: Prof. Bindra Ranjit

Organization: Yale University

Country: USA

Project Name:
 Phase 2 Study of the PARP Inhibitor Olaparib in IDH1/2-mutant solid tumors
Funding Year:
 2018
Project period: 3 years

Phase 2 Study of the PARP Inhibitor Olaparib in IDH1/2-mutant solid tumors

To conduct a comprehensive series of correlative studies in tumor biopsies to identify which patients with IDH1/2 tumor mutations respond best to the DNA repair inhibitor, Olaparib.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.